These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21751829)

  • 1. Delivery outcome after maternal use of drugs for migraine: a register study in Sweden.
    Källén B; Nilsson E; Otterblad Olausson P
    Drug Saf; 2011 Aug; 34(8):691-703. PubMed ID: 21751829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan.
    Källén B; Lygner PE
    Headache; 2001 Apr; 41(4):351-6. PubMed ID: 11318881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triptans in pregnancy.
    Soldin OP; Dahlin J; O'Mara DM
    Ther Drug Monit; 2008 Feb; 30(1):5-9. PubMed ID: 18223456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy outcome following prescription for sumatriptan.
    Olesen C; Steffensen FH; Sorensen HT; Nielsen GL; Olsen J
    Headache; 2000 Jan; 40(1):20-4. PubMed ID: 10759898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination against H1N1 influenza with Pandemrix(®) during pregnancy and delivery outcome: a Swedish register study.
    Källén B; Olausson PO
    BJOG; 2012 Dec; 119(13):1583-90. PubMed ID: 22901103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy outcome following prenatal exposure to triptan medications: a meta-analysis.
    Marchenko A; Etwel F; Olutunfese O; Nickel C; Koren G; Nulman I
    Headache; 2015 Apr; 55(4):490-501. PubMed ID: 25644494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety of sumatriptan and naratriptan in pregnancy: what have we learned?
    Cunnington M; Ephross S; Churchill P
    Headache; 2009; 49(10):1414-22. PubMed ID: 19804390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of sumatriptan in pregnancy: a review of the data so far.
    Loder E
    CNS Drugs; 2003; 17(1):1-7. PubMed ID: 12467489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triptan safety during pregnancy: a Norwegian population registry study.
    Nezvalová-Henriksen K; Spigset O; Nordeng H
    Eur J Epidemiol; 2013 Sep; 28(9):759-69. PubMed ID: 23884894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy outcome after maternal organ transplantation in Sweden.
    Källén B; Westgren M; Aberg A; Olausson PO
    BJOG; 2005 Jul; 112(7):904-9. PubMed ID: 15957990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study.
    Graner S; Svensson T; Beau AB; Damase-Michel C; Engeland A; Furu K; Hviid A; Håberg SE; Mølgaard-Nielsen D; Pasternak B; Kieler H
    BMJ; 2017 Feb; 356():j629. PubMed ID: 28246106
    [No Abstract]   [Full Text] [Related]  

  • 12. Final results from the 16-year sumatriptan, naratriptan, and treximet pregnancy registry.
    Ephross SA; Sinclair SM
    Headache; 2014; 54(7):1158-72. PubMed ID: 24805878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal complications after maternal concomitant use of SSRI and other central nervous system active drugs during the second or third trimester of pregnancy.
    Källén B; Reis M
    J Clin Psychopharmacol; 2012 Oct; 32(5):608-14. PubMed ID: 22926593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery outcome in relation to maternal use of some recently introduced antidepressants.
    Lennestål R; Källén B
    J Clin Psychopharmacol; 2007 Dec; 27(6):607-13. PubMed ID: 18004128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Pregnancy and Perinatal Outcomes Among Women With Epilepsy.
    Razaz N; Tomson T; Wikström AK; Cnattingius S
    JAMA Neurol; 2017 Aug; 74(8):983-991. PubMed ID: 28672292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy outcome and long-term follow-up after in vitro fertilization in women with renal transplantation.
    Norrman E; Bergh C; Wennerholm UB
    Hum Reprod; 2015 Jan; 30(1):205-13. PubMed ID: 25376456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Maternal Eating Disorders With Pregnancy and Neonatal Outcomes.
    Mantel Ä; Hirschberg AL; Stephansson O
    JAMA Psychiatry; 2020 Mar; 77(3):285-293. PubMed ID: 31746972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal obesity and risk of preterm delivery.
    Cnattingius S; Villamor E; Johansson S; Edstedt Bonamy AK; Persson M; Wikström AK; Granath F
    JAMA; 2013 Jun; 309(22):2362-70. PubMed ID: 23757084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal Triptan Exposure and Internalising and Externalising Behaviour Problems in 3-Year-Old Children: Results from the Norwegian Mother and Child Cohort Study.
    Wood ME; Lapane K; Frazier JA; Ystrom E; Mick EO; Nordeng H
    Paediatr Perinat Epidemiol; 2016 Mar; 30(2):190-200. PubMed ID: 26525300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple-micronutrient supplementation for women during pregnancy.
    Haider BA; Bhutta ZA
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD004905. PubMed ID: 28407219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.